Infigratinib is a targeted therapy used to treat certain cancers, including cholangiocarcinoma (bile duct cancer). It works by inhibiting fibroblast growth factor receptors (FGFR), which are involved in tumor growth and metastasis.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Infigratinib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Infigratinib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Infigratinib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
